Table 6.
Luminal A: TP53, MET, and FLT3 mutation status compared with galectin levels.
| Median Galectin | |||||
|---|---|---|---|---|---|
| Concentration (IQR), ng/mL | |||||
| Gene | Count | Galectin | Wild-Type | Mutated | p-Value |
| TP53 | 7 | Gal-1 | 24.70 (19.68–27.76) | 24.97 (16.93–31.76) | 1.0000 |
| Gal-3 | 11.36 (7.89–12.24) | 19.75 (12.24–30.11) | 0.0014 | ||
| Gal-9 | 8.63 (6.64–12.08) | 7.70 (5.76–12.98) | 0.7269 | ||
| MET | 5 | Gal-1 | 24.97 (18.59–27.67) | 24.70 (18.28–30.54) | 0.8548 |
| Gal-3 | 12.67(5.93–18.25) | 11.85 (8.94–16.56) | 0.9271 | ||
| Gal-9 | 7.96 (5.80–11.97) | 14.24 (11.82–16.66) | 0.1055 | ||
| FLT3 | 3 | Gal-1 | 25.28 (20.93–28.93) | (16.88–18.04) | 0.0296 |
| Gal-3 | 11.85 (7.99–16.73) | 12.24 (10.28–19.75) | 0.6470 | ||
| Gal-9 | 8.88 (7.14–12.34) | 5.76 (4.76–5.82) | 0.0362 | ||
Statistically significant findings (p-value < 0.05) are highlighted in red.